Literature DB >> 11286355

Chronic fatigue syndrome: an update.

R J Shephard1.   

Abstract

The chronic fatigue syndrome is characterised by a fatigue that is disproportionate to the intensity of effort that is undertaken, has persisted for 6 months or longer, and has no obvious cause. Unless there has been a long period of patient- or physician-imposed inactivity, objective data may show little reduction in muscle strength or peak aerobic power, but the affected individual avoids heavy activity. The study of aetiology and treatment has been hampered by the low disease prevalence (probably <0.1% of the general population), and (until recently) by a lack of clear and standardised diagnostic criteria. It is unclear how far the aetiology is similar for athletes and nonathletes. It appears that in top competitors, overtraining and/or a negative energy balance can be precipitating factors. A wide variety of other possible causes and/or precipitating factors have been cited in the general population, including psychological stress, disorders of personality and affect, dysfunction of the hypothalamic-pituitary-adrenal axis, hormonal imbalance, nutritional deficits, immune suppression or activation and chronic infection. However, none of these factors have been observed consistently. The prognosis is poor; often disability and impairment of athletic performance are prolonged. Prevention of overtraining by careful monitoring seems the most effective approach in athletes. In those where the condition is established, treatment should aim at breaking the vicious cycle of effort avoidance, deterioration in physical condition and an increase in fatigue through a combination of encouragement and a progressive exercise programme.

Entities:  

Mesh:

Year:  2001        PMID: 11286355     DOI: 10.2165/00007256-200131030-00003

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  273 in total

Review 1.  Report of a workshop on the epidemiology, natural history, and pathogenesis of chronic fatigue syndrome in adolescents.

Authors:  G S Marshall
Journal:  J Pediatr       Date:  1999-04       Impact factor: 4.406

2.  Salivary cortisol profiles in chronic fatigue syndrome.

Authors:  B Wood; S Wessely; A Papadopoulos; L Poon; S Checkley
Journal:  Neuropsychobiology       Date:  1998       Impact factor: 2.328

3.  A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls.

Authors:  P Strickland; R Morriss; A Wearden; B Deakin
Journal:  J Affect Disord       Date:  1998-01       Impact factor: 4.839

4.  [Indications for management in long-term, physically unexplained fatigue symptoms].

Authors:  J W van der Meer; P M Rijken; G Bleijenberg; S Thomas; R J Hinloopen; J M Bensing
Journal:  Ned Tijdschr Geneeskd       Date:  1997-08-02

5.  Lack of seasonal variation of symptoms in patients with chronic fatigue syndrome.

Authors:  D García-Borreguero; J K Dale; N E Rosenthal; A Chiara; A O'Fallon; J J Bartko; S E Straus
Journal:  Psychiatry Res       Date:  1998-02-09       Impact factor: 3.222

6.  Longitudinal changes associated with improvement in chronic fatigue patients.

Authors:  J Russo; W Katon; M Clark; P Kith; M Sintay; D Buchwald
Journal:  J Psychosom Res       Date:  1998-07       Impact factor: 3.006

7.  The epidemiology of chronic fatigue in San Francisco.

Authors:  L Steele; J G Dobbins; K Fukuda; M Reyes; B Randall; M Koppelman; W C Reeves
Journal:  Am J Med       Date:  1998-09-28       Impact factor: 4.965

8.  High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness.

Authors:  B H Natelson; N Ye; D E Moul; F J Jenkins; D A Oren; W N Tapp; Y C Cheng
Journal:  J Med Virol       Date:  1994-01       Impact factor: 2.327

9.  Attention and verbal learning in patients with chronic fatigue syndrome.

Authors:  V Michiels; R Cluydts; B Fischler
Journal:  J Int Neuropsychol Soc       Date:  1998-09       Impact factor: 2.892

10.  Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome.

Authors:  A R Lloyd; S C Gandevia; J P Hales
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

View more
  8 in total

Review 1.  Biochemical aspects of overtraining in endurance sports: a review.

Authors:  Cyril Petibois; Georges Cazorla; Jacques-Rémi Poortmans; Gérard Déléris
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 2.  Trauma-induced systemic inflammatory response versus exercise-induced immunomodulatory effects.

Authors:  Elvira Fehrenbach; Marion E Schneider
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

3.  Skeletal muscle pathology in endurance athletes with acquired training intolerance.

Authors:  L A Grobler; M Collins; M I Lambert; C Sinclair-Smith; W Derman; A St Clair Gibson; T D Noakes
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

4.  Psychomotor speed: possibly a new marker for overtraining syndrome.

Authors:  Esther Nederhof; Koen A P M Lemmink; Chris Visscher; Romain Meeusen; Theo Mulder
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 5.  Effect of Acute Exercise on Fatigue in People with ME/CFS/SEID: A Meta-analysis.

Authors:  Bryan D Loy; Patrick J O'Connor; Rodney K Dishman
Journal:  Med Sci Sports Exerc       Date:  2016-10       Impact factor: 5.411

6.  Can physical assessment techniques aid diagnosis in people with chronic fatigue syndrome/myalgic encephalomyelitis? A diagnostic accuracy study.

Authors:  Lucy Hives; Alice Bradley; Jim Richards; Chris Sutton; James Selfe; Bhaskar Basu; Kerry Maguire; Gail Sumner; Tarek Gaber; Annice Mukherjee; Raymond N Perrin
Journal:  BMJ Open       Date:  2017-11-13       Impact factor: 2.692

7.  Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.

Authors:  Leila Simani; Mahtab Ramezani; Ilad Alavi Darazam; Mastooreh Sagharichi; Mohammad Amin Aalipour; Fatemeh Ghorbani; Hossein Pakdaman
Journal:  J Neurovirol       Date:  2021-02-02       Impact factor: 2.643

8.  Psychosocial predictors of quality of life among South Africa adolescents receiving antiretroviral therapy.

Authors:  A Kagee; B Coetzee; S Du Toit; M E Loades
Journal:  Qual Life Res       Date:  2018-09-22       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.